Literature DB >> 6138539

Non-A, non-B hepatitis from intravenous immunoglobulin.

R S Lane.   

Abstract

Entities:  

Mesh：

Year:  1983        PMID： 6138539     DOI： 10.1016/s0140-6736(83)90496-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  11 in total

Review 1.  New and old aspects of immunoglobulin application. The use of intravenous IgG as prophylaxis and for treatment of infections.

Authors:  L Hammarström; C I Smith
Journal:  Infection       Date:  1990 Sep-Oct       Impact factor: 3.553

2.  Intravenous immune globulin use in children. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.

Authors: 
Journal:  CMAJ       Date:  1992-01-15       Impact factor: 8.262

Review 3.  Criteria for the appropriate drug utilisation of immunoglobulin.

Authors:  P Thürmann; S Harder
Journal:  Pharmacoeconomics       Date:  1996-05       Impact factor: 4.981

4.  Safety of intravenous immunoglobulin treatment.

Authors:  H I Atrah; R J Crawford; B C Dow; R Mitchell
Journal:  J Clin Pathol       Date:  1985-10       Impact factor: 3.411

5.  Idiopathic thrombocytopenic purpura--where do we stand?

Authors:  J S Lilleyman
Journal:  Arch Dis Child       Date:  1984-08       Impact factor: 3.791

6.  HCV infection in patients with primary defects of immunoglobulin production.

Authors:  I Quinti; F Pandolfi; R Paganelli; D el Salman; A Giovannetti; R Rosso; A Oliva; L Rainaldi; F Aiuti
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

7.  Immunoglobulin: production, mechanisms of action and formulations.

Authors:  Marcia Cristina Zago Novaretti; Carla Luana Dinardo
Journal:  Rev Bras Hematol Hemoter       Date:  2011

Review 8.  Virus safety of intravenous immunoglobulin: future challenges.

Authors:  Nicola Boschetti; Martin Stucki; Peter J Späth; Christoph Kempf
Journal:  Clin Rev Allergy Immunol       Date:  2005-12       Impact factor: 8.667

9.  Pathogen inactivation and removal procedures used in the production of intravenous immunoglobulins.

Authors:  Christoph Kempf; Martin Stucki; Nicola Boschetti
Journal:  Biologicals       Date:  2006-04-03       Impact factor: 1.856

Review 10.  Intravenous immunoglobulins: evolution of commercial IVIG preparations.

Authors:  John A Hooper
Journal:  Immunol Allergy Clin North Am       Date:  2008-11       Impact factor: 3.479
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.